Analysis of the Implementation of Informed Consent COVID-19 Vaccination in the Semarang City Region

Abstract

Background : In the data analysis report it was found that in more than 80 countries the number of deaths due to COVID-19. The vaccine in Semarang City has been carried out, the Semarang City Health Service noted, there are 1,216,650 people who have received the first and second doses of the COVID-19 vaccine. The use of informed consent in the COVID-19 vaccine is still very low. It was found that 80% of COVID-19 vaccines used incomplete informed consent in every medical action. The purpose of this study was to determine the implementation of informed consent for COVID-19 vaccination in the Semarang City Region.
 Materials and Methods: The carried out by means of a sampling non-probability sampling technique wasusing purposive sampling, namely a sampling technique with certain considerations made by the researchers themselves, based on characteristics, namely that they had already done a second dose of vaccine and also with the characteristics of the population that had been previously known. The sample is 100 people.
 Results: Informed consent was explained to the patient, not all were informed, because there were still things that had not been explained, such as procedures for action, previous medical history. Informed consent of the COVID-19 vaccine was not given in the first and second doses. However, the majority are given in the first dose. The information provided by health workers at the time of vaccinating COVID-19 did not provide a complete explanation. The explanation to the patient is enough to explain what is important and more orally.
 Conclusion: The implementation of COVID-19 vaccination can be carried out on men and women aged 18-60 years, the implementation of informed consent for COVID-19 vaccination is not in accordance with the applicable laws and regulations, namely the place is not in the right place. give informed consent for the COVID-19 vaccination, the information in the informed consent is still incomplete, so it has not been fully informed to patients. It is recommended to evaluate the implementation of informed consent to see the suitability of its implementation with the laws and regulations.